Ohio State University
320 articles with Ohio State University
Ohio State University Wexner Medical Center Receives Ohio's First Hyperfine Portable MRI Systems to Speed Scanning and Diagnosis for Urgent Brain Injuries
Hyperfine, Inc. is proud to announce that The Ohio State University Wexner Medical Center is deploying two Swoop™ systems in the emergency room, and the Comprehensive Stroke Center operating room.
New Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical Limitations
A new study conducted by The Ohio State University and Abbott showed that half of the adults surveyed living with diabetes did not consume the daily recommended intake of protein, which is associated with lower diet quality, increased carbohydrate intake, and greater physical limitations.
A new study has found potential in a novel gene therapy method to help children born with the rare genetic and neurodegenerative disorder, AADC deficiency.
NMD Pharma A/S announces that it has initiated the ESTABLISH* study, an international observational study in collaboration with Aarhus University and The Ohio State University to assess neuromuscular function in patients with Charcot-Marie-Tooth disease, an inherited neuromuscular disorder of the peripheral nerves characterized by weakness and fatigue.
Battelle, The Ohio State University and Northwestern University Collaborate to Tackle COVID-19 Infodemic in Real Time
Damage from the COVID-19 pandemic has been amplified by the accompanying “infodemic” of false and misleading online information.
Pressure BioSciences and The Ohio State University Announce Food Industry Consortium to Advance Commercialization of PBI's Ultra Shear Technology
Academia-Industry Partnership to Support Improvements in UST Applications and Allow Global Food Companies Access to UST for Preparation of Safer, More Nutritious Liquid Foods and Beverages [24-February-2021] SOUTH EASTON, Mass. , Feb. 24, 2021 /PRNewswire/ --Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broa
As businesses serving the public cope with heightened and ongoing responsibility to help keep patients, customers, employees and students safe from COVID-19 and other pathogens, the College of Education and Human Ecology at The Ohio State University introduces a free, online course on how to help prevent the spread of infection, with a focus on the important role of cleaning and disinfecting in public spaces.
Researchers at Ohio State University are using nanotechnology to boost the body’s ability to fight sepsis, a life-threatening condition that results from the body's extreme reaction to infection.
Management sciences researchers will help agency understand, improve pharmaceutical quality management
A new method of synthesizing molecule arrangements in medicine could change the way many drugs, including the PARP inhibitor Zejula, a treatment for ovarian cancer, are produced.
In Quest to End Cancer, Leading Non-Profit Pelotonia Gives Landmark $102.2 Million for New Immuno-Oncology Institute at The Ohio State University Comprehensive Cancer Center
Immuno-oncology is considered a promising new treatment for detecting and destroying tumors, giving cancer patients hope of a longer life
Madison Startup Otologic Technologies Wins Life Sciences Category in the 2019 Wisconsin Governor's Business Plan Contest
The Wisconsin Technology Council honored Madison-based health tech startup Otologic Technologies, Inc. with their top award in the Life Sciences Category of the Wisconsin Governor's Business Plan Contest on Wednesday, June 5. Otologic Technologies is developing an artificial intelligence system to help doctors better diagnose ear disease.
4/16/2019There is a tendency to look at biotech as being all about developing drugs. And, of course, that is the primary focus of BioSpace. However, from time to time it’s a good idea to remind ourselves that biotech can and does have broader applications besides medicines, and can, in fact, impact our da...
UAHC Subsidiary American Sustainable Rubber Company, LLC Signs Royalty Agreement with The Ohio State University for Exclusive Rights of Genetically Modified TK Rubber Dandelion
United American Healthcare Corporation announced that American Sustainable Rubber Company, LLC and The Ohio State University signed a royalty agreement for exclusive rights within the United States to the genetically modified TK Rubber Dandelion, developed at The Ohio State University, to be grown in an indoor hydroponic system for natural rubber production.
Although that is good news, cancer is the second-most common cause of death in the U.S., with more than 1.7 million new cancer cases each year and more than 600,000 cancer deaths. The report notes that one of the biggest factors in decreased cancer rates are lower tobacco smoking rates.
CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, announced today the successful enrollment of the first patient in the Agili-C Investigational Device Exemption (IDE) pivotal study at The Ohio State University Wexner Medical Center.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today announced the launch of a new non-interventional patient registry, called Tracing the Effect of the MC4R Pathway in Obesity (TEMPO).
Amicus Therapeutics, headquartered in Cranbury, New Jersey, inked a definitive agreement for 10 gene therapy programs licensed from Nationwide Children’s Hospital through the acquisition of Celenex.
Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced the appointment of Stanley Iyadurai, M.D., Ph.D. as Vice President of Clinical Development.
The He Research Group at the Fischell Department of Bioengineering, UMD, uses Linkam temperature- controlled microscopy to study multiscale biomaterials to engineer living cells and tissues for cancer treatment and cell-based medicine.
Market leaders in temperature-controlled microscopy and leaders in sample characterization solutions, Linkam Scientific Instruments, reports on the research of Professor Xiaoming “Shawn” He of the Fischell Department of Bioengineering at the University of Maryland.